Fairmont Regional Cancer Center reopens

Joined WVU Hospitals in May

MORGANTOWN, W.Va. – After three months of facility and equipment upgrades, the Fairmont Regional Cancer Center (FRCC), which joined WVU Hospitals in late May, officially reopened today (Tuesday, Oct. 1).

Located on Locust Avenue in Fairmont, the FRCC provides radiation therapy treatments to cancer patients through a machine called a linear accelerator, which delivers high-energy X-rays to tumors.

When the center officially joined WVU Hospitals on May 29, hospital officials announced that it would close on July 1 to allow for upgrades. Some areas of the facility remain unchanged, while others underwent renovations.

Upgrades to the FRCC were done in order to accommodate the new Varian Linear Accelerator, as well as to meet standards set forth by The Joint Commission, an independent, not-for-profit organization that  accredits and certifies more than 20,000 healthcare organizations and programs in the United States.

Approximately 75,000 pounds of lead shielding was added to the linear accelerator vault in order to adequately shield the X-ray beam.

Services available at the FRCC include advanced external beam radiation therapy treatment techniques, including Intensity Modulated Radiation Therapy for treatment of tumors in the prostate, head and neck, lung and other appropriate sites.

Breast cancer patients will benefit from the utilization of a technique that provides a more even radiation dose to the breast. The FRCC also has technology that can minimize cardiac dose in patients treated in the left breast. Another protocol offered to appropriate breast cancer patients allows them to complete their course of treatment in three weeks instead of the standard six weeks.   

Patients will also be treated using Image Guided Radiation Therapy, which allows healthcare providers to locate and track the tumor at the time of treatment in order to make technical adjustments when a tumor moves outside of the planned treatment range.

The FRCC also has available Rapid Arc®, an advanced technology that delivers a sculpted, tightly-focused beam of radiation directly to a tumor during a single 360-degree rotation of the linear accelerator around the patient. During treatment, the beam is continually shaped and modulated to conform to the shape of the tumor.

Patients at the Fairmont Regional Cancer Center will also have access to specialized treatments on the WVU Healthcare campus, including Perfexion Gamma Knife for brain metastases and selected brain tumors, high dose rate brachytherapy for gynecologic tumors and Stereotactic Body Radiation Therapy (SBRT). SBRT is one of the most advanced forms of radiation therapy delivery and can be used to treat small primary lung tumors in medically inoperable patients, as well as localized lung or liver metastasis, with millimeter precision in five or fewer treatments.

Fairmont Regional Cancer Center patients will have access to Radiation Therapy Oncology Group national clinical trials, as well as other clinical trials available through the Mary Babb Randolph Cancer Center.  

Patients treated at the FRCC will be cared for by the WVU Healthcare’s radiation oncology team, which includes radiation oncologists, medical physicists, dosimetrists, nurses and therapists. Radiation oncologists will be on-site daily to provide care to patients.


For more information:
Angela Jones-Knopf, News Service Coordinator, 304-293-7087
ajk: 09-26-13

Return To News Releases